StockData

Yubo International Biotech Ltd (YBGJ) stock

YBGJOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$0.01+0.00 (0.00%)

Close on Oct 16, 2026Market cap $886.19KP/E –Yield –

Yubo International Biotech cash

Cash and short-term investments held at the end of each period.

Yubo International Biotech's cash was $11.99K at Jun 30, 2026. For fiscal 2026 it was $8.06K, up 14.9% from the year before. Over ten years it grew -3.9% a year on average. The highest annual figure on record is $27.52K in fiscal 2022.

Annual cash

PeriodPeriod endValueChange
FY2026Dec 31, 2025$8.06K+14.9%
FY2025Dec 31, 2024$7.02K+10.3%
FY2024Dec 31, 2023$6.36K-65.1%
FY2023Dec 31, 2022$18.22K-33.8%
FY2022Dec 31, 2021$27.52K+2651.7%
FY2020Feb 29, 2020$1.00K-75.0%
FY2019Feb 28, 2019$4.00K+100.0%
FY2018Feb 28, 2018$2.00K+100.0%
FY2017Feb 28, 2017$1.00K-90.9%
FY2016Feb 29, 2016$11.00K-8.3%
FY2015Feb 28, 2015$12.00K+50.0%
FY2014Feb 28, 2014$8.00K-33.3%
FY2013Feb 28, 2013$12.00K+71.4%
FY2012Feb 29, 2012$7.00K0.0%
FY2011Feb 28, 2011$7.00K+16.7%
FY2010Feb 28, 2010$6.00K–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2027CQ2 2026Jun 30, 2026$11.99K+15.1%
Q1 FY2027CQ1 2026Mar 31, 2026$10.38K+6.2%
Q4 FY2026CQ4 2025Dec 31, 2025$8.06K+14.9%
Q3 FY2026CQ3 2025Sep 30, 2025$10.93K+36.0%
Q2 FY2026CQ2 2025Jun 30, 2025$10.42K+35.3%
Q1 FY2026CQ1 2025Mar 31, 2025$9.77K-82.9%
Q4 FY2025CQ4 2024Dec 31, 2024$7.02K+10.3%
Q3 FY2025CQ3 2024Sep 30, 2024$8.03K+51.7%
Q2 FY2025CQ2 2024Jun 30, 2024$7.70K+48.1%
Q1 FY2025CQ1 2024Mar 31, 2024$57.02K+88.6%
Q4 FY2024CQ4 2023Dec 31, 2023$6.36K-65.1%
Q3 FY2024CQ3 2023Sep 30, 2023$5.30K-94.1%
Q2 FY2024CQ2 2023Jun 30, 2023$5.20K-85.8%
Q1 FY2024CQ1 2023Mar 31, 2023$30.23K+189.7%
Q4 FY2023CQ4 2022Dec 31, 2022$18.22K-33.8%
Q3 FY2023CQ3 2022Sep 30, 2022$89.97K+42.9%
Q2 FY2023CQ2 2022Jun 30, 2022$36.58K-53.9%
Q1 FY2023CQ1 2022Mar 31, 2022$10.44K-91.7%
Q4 FY2022CQ4 2021Dec 31, 2021$27.52K+2651.7%
Q3 FY2022CQ3 2021Sep 30, 2021$62.95K+6195.3%
Q2 FY2022CQ2 2021Jun 30, 2021$79.43K+7842.6%
Q1 FY2022CQ1 2021Mar 31, 2021$126.31K+2005.2%
Q4 FY2020CQ1 2020Feb 29, 2020$1.00K-75.0%
Q3 FY2020CQ4 2019Nov 30, 2019$1.00K-75.0%
Q2 FY2020CQ3 2019Aug 31, 2019$1.00K-66.7%
Q1 FY2020CQ2 2019May 31, 2019$6.00K-14.3%
Q4 FY2019CQ1 2019Feb 28, 2019$4.00K+100.0%
Q3 FY2019CQ4 2018Nov 30, 2018$4.00K+300.0%
Q2 FY2019CQ3 2018Aug 31, 2018$3.00K+200.0%
Q1 FY2019CQ2 2018May 31, 2018$7.00K+600.0%
Q4 FY2018CQ1 2018Feb 28, 2018$2.00K+100.0%
Q3 FY2018CQ4 2017Nov 30, 2017$1.00K–
Q2 FY2018CQ3 2017Aug 31, 2017$1.00K-88.9%
Q1 FY2018CQ2 2017May 31, 2017$1.00K-66.7%
Q4 FY2017CQ1 2017Feb 28, 2017$1.00K-90.9%
Q3 FY2017CQ4 2016Nov 30, 2016$0-100.0%
Q2 FY2017CQ3 2016Aug 31, 2016$9.00K–
Q1 FY2017CQ2 2016May 31, 2016$3.00K–
Q4 FY2016CQ1 2016Feb 29, 2016$11.00K–
Q3 FY2016CQ4 2015Nov 30, 2015$4.00K–

More Yubo International Biotech figures

See a number that looks wrong?